EM, V., F, D., I, P., S, S., HF, L., LB, K., . . . D, v. K. (2026). External validation of PREDICT Breast v3.1 for overall survival in international cohorts, including young and invasive lobular subgroups. Breast cancer research and treatment, 217(2), . https://doi.org/10.1007/s10549-026-07958-w
Chicago Style (17th ed.) CitationEM, Verheul, et al. "External Validation of PREDICT Breast V3.1 for Overall Survival in International Cohorts, Including Young and Invasive Lobular Subgroups." Breast Cancer Research and Treatment 217, no. 2 (2026). https://doi.org/10.1007/s10549-026-07958-w.
MLA (9th ed.) CitationEM, Verheul, et al. "External Validation of PREDICT Breast V3.1 for Overall Survival in International Cohorts, Including Young and Invasive Lobular Subgroups." Breast Cancer Research and Treatment, vol. 217, no. 2, 2026, https://doi.org/10.1007/s10549-026-07958-w.